首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >1-Substituted carbamoyl and thiocarbamoyl-4,5-dihydro-1H-pyrazoles as possible cytotoxic and antimicrobial agents
【24h】

1-Substituted carbamoyl and thiocarbamoyl-4,5-dihydro-1H-pyrazoles as possible cytotoxic and antimicrobial agents

机译:1-取代的氨基甲酰基和硫代羰基-4,5-二氢-1H-吡嗪作为可能的细胞毒性和抗微生物剂

获取原文
获取原文并翻译 | 示例
           

摘要

Two series of 1-substituted carbamoyl and thiocarbomoyl derivatives were prepared by either treating the corresponding pyrazole with the appropriate isocyanate and isothiocyanate respectively, or alternatively by condensing the appropriate diketone with the proper substituted semicarbazide or thiosemicarbazide. The structures of the prepared compounds were fully determined by analytical and spectral methods. Preliminary biological screening of the prepared compounds revealed significant antibacterial and cytotoxic activities for some compounds. Compounds 4a(2) and 4a(3) were found to be the most active against the human colon carcinoma HT29 (11.8 and 7.5 mu g/mL, respectively) and human breast cancer MCF 7 (3.4 and 2.6 mu g/mL, respectively) cell lines. The structure-activity relationship (SAR) and in silico drug relevant properties (HBD, HBA, tPSA, cLog P, molecular weight, % ABS, drug-likeness and drug score) further confirmed that the compounds are potential lead compounds for future drug discovery study.
机译:通过将相应的吡唑分别用适当的异氰酸酯和异硫氰酸酯处理,或者通过用适当的取代的氨基脲或硫代氨基甲基脱甲酸脱硫,或者通过用适当的取代的氨基脲或硫代喹甲酸脱氨酸来制备两种1取代的氨基甲酰和硫酰吡酰衍生物。通过分析和光谱方法完全确定制备的化合物的结构。制备的化合物的初步生物学筛选显示出一些化合物的显着抗菌和细胞毒性活性。发现化合物4a(2)和4a(3)是对人结肠癌HT29(11.8和7.5μg/ ml)和人乳腺癌MCF 7(3.4和2.6μg/ ml的最活性) 细胞系。结构 - 活性关系(SAR)和硅药物相关性质(HBD,HBA,TPSA,CLOG P,分子量,%ABS,药物相似性和药物评分)进一步证实了化合物是未来药物发现的潜在铅化合物学习。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号